Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial

医学 压力源 不利影响 重症监护医学 内科学 心房颤动 风险因素 风险评估 初级保健 急诊医学 心力衰竭 心脏病学 抗凝剂 梅德林 临床试验 随机对照试验 心血管事件 风险管理 临床实习
作者
Julian S. Haimovich,Shinwan Kany,Yuchiao Chang,Leila H. Borowsky,David D. McManus,Steven J. Atlas,Daniel E. Singer,Steven A. Lubitz,Patrick T. Ellinor,Shaan Khurshid
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:153 (6): 367-378 被引量:1
标识
DOI:10.1161/circulationaha.125.076421
摘要

BACKGROUND: Stressor-associated atrial fibrillation (AF), defined as newly diagnosed AF in the setting of a reversible physiological stressor, is common. However, risk factors, outcomes, and current management practices remain poorly understood. METHODS: We analyzed data from VITAL-AF, a pragmatic, cluster-randomized AF screening trial conducted in 2018 and 2019 comprising adults ≥65 years of age across 16 primary care practices affiliated with Massachusetts General Hospital. All participants had longitudinal follow-up for adjudicated incident AF (including whether stressor-associated versus nonstressor-associated ["primary"]) and clinical outcomes. We compared associations between clinical AF risk factors and incident AF group (stressor-associated versus primary) using Fine-Gray models handling death and each AF group as competing risks. We also quantified oral anticoagulant initiation rates after AF diagnosis. We then fit Cox proportional hazards models to quantify associations between incident AF group (as a time-varying covariate) and a composite end point of major bleeding, stroke, and all-cause mortality, with adjustment for CHA₂DS₂-VASc (congestive heart failure, hypertension, age >74, diabetes, stroke or transient ischemic attack or thromboembolism, vascular disease, age 65-74, sex category; stroke) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation; bleeding) scores and time-varying oral anticoagulant exposure. RESULTS: <0.001). The incidence of the composite end point was 2.30 per 100 person-years (95% CI, 2.17-2.44) for no AF, 15.09 (95% CI, 12.22-18.42) for primary AF, and 22.71 (95% CI, 16.91-29.87) for stressor-associated AF. In adjusted models and using no AF as the referent, both primary AF (hazard ratio [HR], 3.91 [95% CI, 2.89-5.28]) and stressor-associated AF (HR, 6.13 [95% CI, 4.31-8.72]) were associated with substantially higher risk of the composite end point. CONCLUSIONS: Among >30 000 primary care patients with adjudicated AF events, nearly one-third of incident AF cases were stressor associated. Despite similar risk factor profiles and comparably high rates of adverse outcomes, oral anticoagulant initiation is lower when AF is stressor associated. Future work is needed to define optimal approaches to prevention, surveillance, and management of stressor-associated AF.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小陈小陈完成签到,获得积分10
刚刚
KIte完成签到,获得积分10
1秒前
bkagyin的应助被Nodi采纳,获得10
1秒前
wsyyyyy发布了新的文献求助10
1秒前
hetao286完成签到,获得积分10
2秒前
2秒前
科研通AI6.4的应助被超级无敌采纳,获得10
2秒前
困了就先睡完成签到,获得积分10
2秒前
2秒前
LZH驳回了丘比特的应助
2秒前
Li完成签到,获得积分10
3秒前
魔幻的香芦完成签到,获得积分10
3秒前
123发布了新的文献求助10
4秒前
lzz发布了新的文献求助10
4秒前
独一完成签到,获得积分10
5秒前
5秒前
5秒前
老迟到的醉卉完成签到,获得积分10
6秒前
uoe完成签到,获得积分10
6秒前
syvshc的应助被晚晚采纳,获得10
7秒前
zhuoak完成签到,获得积分10
7秒前
syvshc的应助被Irene采纳,获得10
7秒前
7秒前
sasakiki发布了新的文献求助10
7秒前
高高的冷之完成签到,获得积分10
8秒前
英俊的铭的应助被xiaowei666采纳,获得10
9秒前
蜉蝣发布了新的文献求助10
10秒前
星辰大海的应助被uoe采纳,获得10
10秒前
11秒前
12秒前
Zhuo发布了新的文献求助10
12秒前
可爱的函函的应助被烂漫冰烟采纳,获得10
12秒前
13秒前
高兴芒果完成签到,获得积分10
13秒前
慕青的应助被liu采纳,获得10
13秒前
13秒前
Ava的应助被hhhxjv采纳,获得10
13秒前
一个O完成签到,获得积分10
14秒前
14秒前
无书寄贵人完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192020
求助须知:如何正确求助?哪些是违规求助? 9578648
关于积分的说明 21861105
捐赠科研通 7791458
什么是DOI,文献DOI怎么找? 3436765
关于科研通互助平台的介绍 2560502
邀请新用户注册赠送积分活动 2483544